<DOC>
	<DOCNO>NCT00856817</DOCNO>
	<brief_summary>The purpose study determine whether heme oxygenase 1 induction heme arginate treatment influence adenosine induce vasodilation healthy individual .</brief_summary>
	<brief_title>Heme Oxygenase ( HO ) Activity Adenosine Induced Vasodilation</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>least 18 old 65 day first dose healthy Quetelet Index ( Body Mass Index ) 18 30 kg/m2 In general , result haematology chemistry within laboratory 's reference range . Determinants renal hepatic function within twice upper limit normal range . Documented history sensitivity / idiosyncrasy medicinal product excipients history smoking within past year history current abuse drug , alcohol and/or solvent Current use ( counter ) medication potentially influencing heme oxygenase cardiovascular system Inability understand nature extent trial procedure require Participation drug trial within 60 day prior first dose Febrile illness within 3 day first dose Heterozygosity ( LS ) homozygosity ( LL ) regard number GT repeat HO1 promoter region</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>